ustainable Development Goals (SDGs), as well as with its stakeholders’ interests in sustainable business performance.
– One example of WuXi Biologics’ contribution to society is its rapid, robust pandemic response — enabling nearly 30 Investigational New Drug Applications (INDs) for COVID-19 projects, manufacturing more than 1500kg of COVID-19 neutralizing antibody, and delivering hundreds of millions COVID-19 vaccine doses.
– WuXi Biologics has set mid- to long-term targets to reduce greenhouse gas (GHG) emissions intensity of Scope 1 and Scope 2 by 50% by 2030 compared with 2020, and achieve a 18% reduction in water consumption intensity by 2025 compare with 2019. The company outperformed its 2021 targets, reducing GHG emissions intensity by 8% and water consumption intensity by 13%.
– A culture of diversity, equity and inclusion (DEI) is cultivated and well managed at WuXi Biologics. The number of employees in China, Ireland, the United States, Germany and Singapore has surpassed 10,000, of which more than 53% are women.
– As part of global corporate social responsibility (CSR), WuXi Biologics encourages its workforce to contribute to the welfare of their localities around the world. In 2021, 798 employee volunteers from nine cities in four countries – mobilized by the “PROUD” culture – contributed a total of 3,192 service hours to their local communities.
– WuXi Biologics’ response to the July 2021 Henan floods included an immediate CNY 10 million donation for disaster relief by the WuXi Biologics Charity Foundation, programs to subsidize reconstruction efforts and financial support from the company for impacted employees.
– WuXi Biologics is committed to building a sustainable supply chain and leveraging a “Multi-Sourcing and Safety Stock” approach to mitigate any potential risks from supply chain disruptions, which allow the company to ensure the delivery of high-quality products and services to clients.
– WuXi Biologics’ efforts have been widely recognized by the rating agencies, including being named by Sustainalytics as an “ESG Industry Top-Rated Company” for comprehensive compliance management.
HONG KONG, April 27, 2022 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, published its Environmental, Social and Governance (ESG) Report of 2021. It comprehensively introduces what the company has achieved on greening development, enabling clients, giving back to society and responsible governance in the past year.
In 2021, WuXi Biologics established a CEO-led ESG committee at the board level. The company also set up an ESG steering group and an ESG department. WuXi Biologics aligns its goals with the United Nations Sustainable Development Goals (SDGs) and has enhanced its ESG strategy accordingly. Throughout the year, the company’s ESG governance structure was continuously optimized to ensure that the sustainable development concept remains entrenched in the company’s strategy and provides an overarching context for its daily operations, creating maximum benefit for both society and the environment.
Greening Development
To actively address climate change, WuXi Biologics set a mid- to long-term greenhouse gas (GHG) emissions reduction and water consumption target: reduce its ratio of Scope 1 and Scope 2 GHG emissions intensity by 50% by 2030 compared with 2020, and deliver an 18% reduction in water consumption intensity by 2025 from a 2019 base year. An independent and accredited professional agency’s comprehensive audit in 2021– based on the ISO 14064 standard – confirmed an 8% year-on-year decrease in GHG emissions intensity.
In addition, WuXi Biologics’ large-scale adoption of environmentally friendly single-use technology saves approximately 70% of water and 30% of energy compared to traditional stainless-steel technology. The application of single-use technology also helped to decrease water consumption intensity by 13% year on year and improve energy efficiency for three consecutive years.
Sharing on sustainability efforts for green manufacturing, the biologics facilities in Dundalk, Ireland is designed to save energy, reduce emission and recycle resource. Expected to be operational soon, the site has fully applied WuXi Biologic’s “Factory of the Future” principles. In China sites, energy efficiency is improved through a series of energy-saving initiatives and green development concepts including reutilizing steam condensate.
Enabling Clients